Search
Hemab Therapeutics Holdings Ord Shs (Proposed)
COAGAdd to Watchlist
36.000USD
-0.730-1.99%
Market hours 09/24, 10:15（ET）
1.68BMarket Cap
0.00P/E TTM
COAG Financials
See Hemab Therapeutics Holdings Ord Shs (Proposed)'s financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
1.68B
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
0.00
Revenue
--
Net Profit
0.00
ROE
0.00%
ROA
0.00%
Hemab Therapeutics Holdings Ord Shs (Proposed) Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.52/-0.74
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What are the current assets of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its current assets were 192.55M, with a year-on-year change of 106.52.
What are the total assets of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its total assets of Hemab Therapeutics Holdings Ord Shs (Proposed) were 194.78M, with a year-on-year change of 102.31.
What are the total liabilities of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its total liabilities of Hemab Therapeutics Holdings Ord Shs (Proposed) were 11.25M, with a year-on-year change of 44.16.
What is the total equity of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its total equity of Hemab Therapeutics Holdings Ord Shs (Proposed) was 183.53M, with a year-on-year change of 107.44.
What is the net operating income of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its net operating income of Hemab Therapeutics Holdings Ord Shs (Proposed) was -70.12M, with a year-on-year change of -39.17.
What is the net investment of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its net investment of Hemab Therapeutics Holdings Ord Shs (Proposed) was -81.48M, with a year-on-year change of -231.63.
What is the net financing of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its net financing of Hemab Therapeutics Holdings Ord Shs (Proposed) was 156.30M, with a year-on-year change of 156401.00.
What is the net income of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its net income was -63.91M, with a year-on-year change of -31.22.
What is the operating profit of Hemab Therapeutics Holdings Ord Shs (Proposed)?
According to Hemab Therapeutics Holdings Ord Shs (Proposed)'s FY2025 earnings report, its operating profit was -70.12M, with a year-on-year change of -39.17.